Harmony Biosciences Holdings (HRMY) — Cash Flow Reinvestment Rate
Harmony Biosciences Holdings (HRMY) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting $4.86 Million (capex $71.00K plus investments $-4.79 Million) from operating cash flow of $108.73 Million. Explore HRMY capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Harmony Biosciences Holdings Cash Flow Reinvestment Rate (2021–2024)
Historical reinvestment intensity for Harmony Biosciences Holdings across 4 annual periods. Also explore balance sheet size of Harmony Biosciences Holdings for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Harmony Biosciences Holdings (2021–2024)
Year-by-year capital reinvestment analysis for Harmony Biosciences Holdings. For live market cap and broader valuation context, see Harmony Biosciences Holdings (HRMY) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.31x | $68.64 Million | $219.82 Million | $1.15 Million | ▲ +19.0% |
| 2023 | 0.26x | $57.58 Million | $219.39 Million | $312.00K | ▼ -73.3% |
| 2022 | 0.98x | $142.00 Million | $144.47 Million | $172.00K | ▼ -3.7% |
| 2021 | 1.02x | $100.60 Million | $98.56 Million | $298.00K | — |